Sin-Yeang (Ronald) Teow

  • Position:
    Assistant Professor of Biology
  • College:
    College of Science, Mathematics and Technology
  • Office:
    CSMT 335

Education background

B.S. (Hons) in Biotechnology, 2010

University of Sunderland, United Kingdom

 

PhD in Molecular Virology and Oncology, 2015

University Science Malaysia

Courses teaching at WKU

General Biology II (B.S)

Molecular Biology of Cancer (M.S)

Cellular and Molecular Techniques (M.S)

Cancer Biology (B.S)

Biography

After PhD completion, Ronald obtained his post-doctoral training in the National Institute of Health, Institute for Medical Research Malaysia, investigating the pathogenicity of Epstein-Barr virus in the development of nasopharyngeal carcinoma using multicellular and xenograft models. In 2016, he joined Sunway University, Malaysia as a Research Fellow and was awarded the Vice Chancellor Early Career Researcher in 2018. He was then promoted to Associate Professor in 2022 before joining WKU in Spring 2023. Ronald’s current research focuses on developing potent anticancer nanotherapeutics against solid tumors, particularly in colorectal cancer. He has received grants cumulatively ~RMB 3 million during his research career in Malaysia and published more than 70 peer-reviewed academic papers including 1 patent and several invited book chapters. Ronald has graduated or is supervising close to 15 graduate students from WKU and Malaysian universities. He also actively serves as an external examiner for PhD thesis of various universities. In 2022, he was listed as one of the top 2% scientist in the discipline of Clinical Medicine, subfields of Pharmacology/ Pharmacy & Chemical Physics for year 2021 alone.

Research Interests

Cancer nanotherapeutics

Cancer biology

Editor/ Special Issue Editor

Frontiers in Oncology

MDPI Inorganics

Asia Pacific Journal of Molecular Biology & Biotechnology

Journal reviewer

Molecular Cancer

Carbohydrate Polymers

Bioconjugate Chemistry

Journal of Molecular Liquids

Microbial Cell Factories

Pharmaceutics

Life Sciences

Applied Microbiology and Biotechnology

Biomedicine and Pharmacotherapy

Scientific Reports

International Journal of Molecular Sciences

Cannabis and Cannabinoid Research

Ceramics International

Arabian Journal of Chemistry

Frontiers in Cellular and Infection Microbiology

International Journal of Nanomedicine

Frontiers Bioengineering and Biotechnology

Cancer Medicine

Selected Publications

  1. Yusefi M, Shameli K, Jahangirian H, Teow SY, et al. (2023) How magnetic composites are effective anticancer therapeutics? A comprehensive review of the literature. International Journal of Nanomedicine 3535-3575 (IF–8.0)
  2. Mohamad Sukri SNA, Shameli K, Teow SY et al. (2023) Enhanced antibacterial and anticancer activities of plant extract mediated green synthesized zinc oxide-silver nanoparticles. Frontiers in Microbiology 14, 1194292. (IF–5.2)
  3. Yusefi M, Shameli K, Soon MLK, Teow SY et al. (2023) Chitosan coated magnetic cellulose nanowhisker as a drug delivery system for potential colorectal cancer treatment. International Journal of Biological Macromolecules, 123388 (IF–8.2)
  4. Lee KX, Shameli K, Nagao Y, Yew YP, Teow SY et al. (2023) Potential use of gold-silver core-shell nanoparticles derived from Garcinia mangostana peel for anticancer compound, protocatechuic acid delivery. Frontiers in Molecular Biosciences, 16648714 (IF–5.0)
  5. Yusefi M, Soon MLK, Teow SY et al. (2022) Fabrication of cellulose nanocrystals as potential anticancer drug delivery systems for colorectal cancer treatment. International Journal of Biological Macromolecules, 199, 372-385 (IF–8.2)
  6. Ismail NA, Shameli K, Mohamad Sukri SNA, Hara H, Teow SY et al. (2022) Sonochemical synthesis of a copper reduced graphene oxide nanocomposite using honey and evaluation of its antibacterial and cytotoxic activities. Frontiers in Molecular Biosciences, 9, 995853 (IF–5.0)
  7. Yusefi M, Soon MLK, Shameli K, Teow SY et al. (2021) 5-fluorouracil loaded magnetic cellulose bionanocomposites for potential colorectal cancer treatment. Carbohydrate Polymers, 118523. (IF–11.2)
  8. Yusefi M, Shameli K, Yee OS, Teow SY, et al (2021) Green synthesis of Fe3O4 nanoparticles stabilized by a Garcinia mangostana fruit peel extract for hyperthermia and anticancer activities. International Journal of Nanomedicine 16, 2515. (IF–8.0)
  9. Yusefi M, Chan HY, Teow SY et al. (2021) 5-fluorouracil encapsulated chitosan-celluose fiber cellulose bionanocomposites: Synthesis, characterization and in vitro analysis towards colorectal cancer cells. Nanomaterials, 11(7), 1691. (IF–5.3)
  10. Yew YP, Shameli K, Mohamad SE, Lee KX, Teow SY (2020) Green synthesized montmorillonite/carrageenan/Fe3O4 nanocomposites for pH-responsive release of protocatechuic acid and its anticancer activity. International Journal of Molecular Sciences 21(14), 4851. (IF–5.6)
  11. Lee KX, Shameli K, Yew YP, Teow SY, et al (2020) Recent developments in the facile bio-synthesis of gold nanoparticles (AuNPs) and their biomedical applications. International Journal of Nanomedicine 15, 275. (IF–8.0)
  12. Yusefi M, Shameli K, Jahangirian H, Teow SY, et al (2020) The potential anticancer activity of 5-fluorouracil loaded in cellulose fibers isolated from rice straw. International Journal of Nanomedicine 15, 5417. (IF–8.0)
  13. Tan HL, Kai D, Pasbakhsh P, Teow SY, et al. (2020) Electrospun cellulose acetate butyrate/polyethylene glycol (CAB/PEG) composite nanofibers: a potential scaffold for tissue engineering. Colloids and surfaces B: Biointerfaces 188, 110713. (IF–5.8)
  14. Izadiyan Z, Shameli K, Miyake M, Teow SY, et al (2019) Green fabrication of biologically active magnetic core-shell Fe3O4/ Au and their cytotoxic effect. Materials Science and Engineering: C. 96, 51-57.  (IF–7.328)
  15. Ismail NA, Shameli K., Wong MMT, Teow SY, et al (2019) Antibacterial and cytotoxic effect of honey mediated copper nanoparticles synthesized using ultrasonic assistance. Materials Science and Engineering: C. 104, 109899. (IF–7.328)
  16. Yew YP, Shameli K, Mohamad SE, Nagao Y, Teow SY, et al (2019) Potential anticancer activity of protocatechuic acid loaded in montmorillonite/Fe3O4 nanocomposites stabilized by seaweed Kappaphycus alvarezii. International Journal of Pharmaceutics 572, 118743. (IF–5.8)
  17. Yap HY, Tee SZY, Wong MMT, Chow SK, Peh SC, Teow SY. (2018) Pathogenic role of immune cells in rheumatoid arthritis (RA): Implications in clinical treatment and biomarker development. Cells 7(10), 161. (IF–6.0)

Patent

Khoo ASB, Abdul Aziz N, Teow SY, et al. Isolated nasopharyngeal carcinoma cells and derivatives prepared thereof. US20210395696A1, US Patent App. 17/289, 132, 2021

Selected Research Grants

  1. 2022-2024 Ministry of Education Malaysia Fundamental Research Grant Scheme (FRGS/1/2022/SKK10/SYUC/02/4) ‘Elucidating determinant factors that enhance transcytosis and the anticancer efficacy of a chitosan nanogel-loaded with 5-fluorouracil in colorectal cancer’ ~RMB 260,870
  2. 2021-2023 Sunway-Cambridge Collaboration Fund (STR-CAMMED-SET-000-2021) ‘Low dose radiation and cellular response’ ~RMB 699,569
  3. 2020-2021 Sunway Internal Research Grant (GRTIN-RSF-SHMS-DMS-03-2020) ‘Generation of exosomes loaded with anticancer iron oxide nanoparticles (IONPs) for targeted delivery with hyperthermia treatment in colon cancer’ ~RMB 57,971
  4. 2019-2023 Ministry of Education Malaysia Fundamental Research Grant Scheme (FRGS/1/2019/SKK08/SYUC/02/1) ‘Investigating the role of SIRT1-autophagy regulatory axis in chemoresistance in hepatocellular carcinoma (HCC) using 3D tumour spheroid in vitro model’ ~RMB 272,323
  5. 2018-2021 Sunway Internal Research Grant 2018 (SRC/003/2017/FR) ‘Investigating the role of KRAS in autophagy in colorectal cancer (CRC) and its implications in therapy response and patient survival and the potential use of autophagy marker as CRC biomarker’ ~RMB 78,183
  6. 2017-2019 MAKNA Cancer Research Grant Award (EXT-SIDS-SIHD-MAKNA-2017-01) ‘Defining the role of KRAS in autophagy in colorectal cancer and implications in predicting response to therapy in advanced stage colorectal cancers and overall patient survival’ ~RMB 47,000